These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 3136361

  • 1. Acute opioid physical dependence in humans: naloxone dose response effects.
    Heishman S, Stitzer M.
    NIDA Res Monogr; 1988; 81():195-201. PubMed ID: 3136361
    [No Abstract] [Full Text] [Related]

  • 2. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
    Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
    [Abstract] [Full Text] [Related]

  • 3. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
    Bickel WK, Stitzer ML, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
    [Abstract] [Full Text] [Related]

  • 4. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK, Bhateja P, Singh TG, Singh N.
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [Abstract] [Full Text] [Related]

  • 5. Morphine physical dependence in the dog.
    Martin WR, Eades CG, Thompson WO, Thompson JA, Flanary HG.
    J Pharmacol Exp Ther; 1974 Jun; 189(3):759-71. PubMed ID: 4858404
    [No Abstract] [Full Text] [Related]

  • 6. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
    Preston KL, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Opiate abstinence head-shaking model in infant rats.
    Pérez-Saad H, Figueredo P, Urba-Holmgren R.
    Bol Estud Med Biol; 1989 Mar; 33(1-8):13-24. PubMed ID: 6545124
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    Schuh KJ, Walsh SL, Bigelow GE, Preston KL, Stitzer ML.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
    [Abstract] [Full Text] [Related]

  • 14. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY, Friedman E, Olmstead MC, Burns LH.
    Neuroscience; 2005 Aug; 135(1):247-61. PubMed ID: 16084657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
    Jones KL, Barr GA.
    Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists.
    Jacob JJ, Barthelemy CD, Tremblay EC, Colombel MC.
    Adv Biochem Psychopharmacol; 1973 Feb; 8(0):299-318. PubMed ID: 4800176
    [No Abstract] [Full Text] [Related]

  • 19. The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawal.
    Bergeria CL, Huhn AS, Tompkins DA, Bigelow GE, Strain EC, Dunn KE.
    Drug Alcohol Depend; 2019 Sep 01; 202():111-114. PubMed ID: 31336328
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
    Capasso A, Di Giannuario A, Loizzo A, Pieretti S, Sagratella S, Sorrentino L.
    J Pharmacol Exp Ther; 1996 Feb 01; 276(2):743-51. PubMed ID: 8632345
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.